The Panel expresses its gratitude for thoughtful reviews of an earlier version by Anthony Bryceson, Pierre Buffet, James Maguire, Henry Murray, Abhay Satoskar, as well as Edward Ryan (Chair) and members of the ASTMH Standards and Treatment Guidelines Committee. The panel also thanks Dean Winslow, the liaison of the IDSA Standards and Practice Guidelines Committee, and Genet Demisashi for their efforts guiding us through the process.
Guyatt GH, Oxman AD, Vist GE et al.. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed) 2008; 336(7650): 924–6
Magill A. Leishmania species. Chapter 277, In: Principles and practice of infectious diseases. 8th ed. Philadelphia, PA: Elsevier, 2015: 3091–107.
World Health Organization. Control of the leishmaniases. World Health Organization technical report series. Geneva, Switzerland: WHO, 2010; 949: xii–xiii, 1–186, back cover.
Sundar S, Mehta H, Suresh AV, Singh SP, Rai M, Murray HW. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin Infect Dis 2004; 38: 377–83.
Laguna F, Videla S, Jimenez-Mejias ME et al.. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study. J Antimicrob Chemother 2003; 52: 464–8.